pipette
ESEspañol

Citron kinase activity controls alternative splicing events that drive prostate cancer growth

Chitra Rawat, Nidhi Singh, Ujjwal Ranjan Dahiya, Qiang Hu, Sarah Ng, Dingxiao Zhang, Shaun R. Stauffer, Amina Zoubeidi, Eva Corey, Jesse McKenney, Christopher Weight, Samuel Haywood, Song Liu, Tao Liu, Hannelore V. Heemers

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Thus, CIT-mediated alternative splicing drives CaP progression, and its inhibition is a new therapeutic strategy in treatment-resistant CaP.

Appeared: Sunday, October 11. Science Advances. Peer-reviewed journal.

DOI: 10.1126/sciadv.aee5257